BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12083479)

  • 1. Polymorphonuclear leucocytes have two opposing roles in fibrinolysis.
    Moir E; Robbie LA; Bennett B; Booth NA
    Thromb Haemost; 2002 Jun; 87(6):1006-10. PubMed ID: 12083479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphonuclear leukocytes from patients with severe sepsis have lost the ability to degrade fibrin via u-PA.
    Moir E; Greaves M; Adey GD; Bennett B
    J Leukoc Biol; 2004 Sep; 76(3):571-6. PubMed ID: 15277568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gold sodium thiomalate on fibrinolysis.
    Moroz LA
    J Rheumatol Suppl; 1979; 5():149-53. PubMed ID: 158655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphonuclear leukocytes regulate the plasminogen-activating system of cultured endothelial cells.
    Gilboa N; Neumann PH; Del Vecchio PJ; Gudewicz PW
    Biochem Int; 1988 Sep; 17(3):585-92. PubMed ID: 3264500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the activation mechanism of fibrinolytic enzyme system in plasma by human pancreatic elastase.
    Toki N; Takasugi S; Ishizu K; Sato H; Sumi H
    Thromb Haemost; 1982 Feb; 47(1):8-13. PubMed ID: 6176043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer.
    Foekens JA; Ries C; Look MP; Gippner-Steppert C; Klijn JG; Jochum M
    Cancer Res; 2003 Jan; 63(2):337-41. PubMed ID: 12543785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors.
    Kolev K; Komorowicz E; Machovich R
    Blood Coagul Fibrinolysis; 1994 Dec; 5(6):905-11. PubMed ID: 7534486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of homocysteine on fibrin network lysis.
    Lauricella AM; Quintana I; Castañon M; Sassetti B; Kordich L
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):181-6. PubMed ID: 16575255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic activity of normal human blood monocytes.
    Grau E; Moroz LA
    Thromb Res; 1989 Jan; 53(2):145-62. PubMed ID: 2922705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.
    Castañon MM; Gamba C; Kordich LC
    Thromb Res; 2007; 120(5):745-52. PubMed ID: 17270255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired fibrinolytic potential related to elevated alpha1-proteinase inhibitor levels in patients with pulmonary thromboembolism.
    Gombás J; Kolev K; Tarján E; Machovich R
    Ann Hematol; 2004 Dec; 83(12):759-63. PubMed ID: 15316758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolytic activity and species of plasminogen activator in human tears.
    Hayashi K; Sueishi K
    Exp Eye Res; 1988 Feb; 46(2):131-7. PubMed ID: 3127227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors.
    Kolev K; Léránt I; Tenekejiev K; Machovich R
    J Biol Chem; 1994 Jun; 269(25):17030-4. PubMed ID: 7516329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluids.
    Braat EA; Nauland U; Dooijewaard G; Rijken DC
    Thromb Haemost; 1996 Jun; 75(6):908-14. PubMed ID: 8822585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative comparison of fibrin degradation with plasmin, miniplasmin, neurophil leukocyte elastase and cathepsin G.
    Kolev K; Komorowicz E; Owen WG; Machovich R
    Thromb Haemost; 1996 Jan; 75(1):140-6. PubMed ID: 8713793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot.
    Bagoly Z; Haramura G; Muszbek L
    Thromb Haemost; 2007 Aug; 98(2):359-67. PubMed ID: 17721618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of inflammatory cells and their proteases in extravascular fibrinolysis.
    Heiden M; Seitz R; Egbring R
    Semin Thromb Hemost; 1996; 22(6):497-501. PubMed ID: 9122714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.
    Liu JW; Wei DZ; Du CB; Zhong JJ
    Acta Pharmacol Sin; 2003 Feb; 24(2):102-8. PubMed ID: 12546716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.